SARS_CoV_2 Infection Clinical Trials in Anaheim

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥12 Years of Age.
Active, not recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Placebo
  • Athens, Alabama
  • +144 more
2021-12-21
Dec 21, 2021
B
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b1
  • +3 more
  • Athens, Alabama
  • +165 more
2021-12-21
Dec 21, 2021
B
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults - 2021
Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
2021-12-17
Dec 17, 2021
P
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2
Active, not recruiting
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +26 more
2021-08-02
Aug 2, 2021